Gender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumors

RAUL MIGUEL LUQUE HUERTAS2026-01-292026-01-29202110.3390/cancers131230972-s2.0-85108233956https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/33567Cancer ResearchOncologyGender-specific efficacy revealed by head-to-head comparison of pasireotide and octreotide in a representative in vivo model of nonfunctioning pituitary tumorsresearch article